Search Results - E. Kimber
- Showing 1 - 7 results of 7
-
1
-
2
3118 Hemichorea under the magnifying glass by Stephen Bacchi, Rudy Goh, Andreas Makestas, Thomas E Kimber, Mawathage Seneviratne
Published in BMJ Neurology Open (2024-08-01)Article -
3
Faecal microbiota transplant in Parkinson’s disease: pilot study to establish safety & tolerability by Michele De Sciscio, Robert V. Bryant, Sarah Haylock-Jacobs, Alice S. Day, William Pitchers, Robert Iansek, Samuel P. Costello, Thomas E. Kimber
Published in npj Parkinson's Disease (2025-07-01)Get full text
Article -
4
Non-destructive insect metabarcoding as a surveillance tool for the Australian grains industry: a first trial for the iMapPESTS smart trap by Francesco Martoni, Reannon L. Smith, Alexander M. Piper, Narelle Nancarrow, Mohammad Aftab, Piotr Trebicki, Rohan B. E. Kimber, Brendan C. Rodoni, Mark J. Blacket
Published in Metabarcoding and Metagenomics (2023-02-01)Get full text
Article -
5
High intensity interval training in a real world setting: a randomized controlled feasibility study in overweight inactive adults, measuring change in maximal oxygen uptake. by Helen Lunt, Nick Draper, Helen C Marshall, Florence J Logan, Michael J Hamlin, Jeremy P Shearman, James D Cotter, Nicholas E Kimber, Gavin Blackwell, Christopher M A Frampton
Published in PLoS ONE (2014-01-01)Get full text
Article -
6
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study by Jason Aldred, Eric Freire-Alvarez, Alexander V. Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K. Ray Chaudhuri, Susan R. Criswell, Erik H. Danielsen, Florin Gandor, Jia Jia, Thomas E. Kimber, Hideki Mochizuki, Weining Z. Robieson, Amy M. Spiegel, David G. Standaert, Saritha Talapala, Maurizio F. Facheris, Victor S. C. Fung
Published in Neurology and Therapy (2023-08-01)Get full text
Article -
7
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study by Jason Aldred, Eric Freire-Alvarez, Alexander V. Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K. Ray Chaudhuri, Susan R. Criswell, Erik H. Danielsen, Florin Gandor, Jia Jia, Thomas E. Kimber, Hideki Mochizuki, Weining Z. Robieson, Amy M. Spiegel, David G. Standaert, Saritha Talapala, Maurizio F. Facheris, Victor S. C. Fung
Published in Neurology and Therapy (2023-10-01)Get full text
Article
